<DOC>
	<DOCNO>NCT00957060</DOCNO>
	<brief_summary>Primary Objective : To determine superiority glimepiride sitagliptin reduction HbA1c 6 month treatment patient monotherapy end trial . Secondary Objective : To evaluate effect glimepiride compare sitagliptin : Glucose fast condition ; Postprandial glucose ; Percentage patient HbA1c &lt; 7 % &lt; 6.5 % ; Symptomatic Hypoglycemia ; Body weight ; Percentage withdrawal percentage patient rescue therapy ; Safety ( adverse event serious adverse event , hypoglycemia , vital sign laboratory result ) .</brief_summary>
	<brief_title>Superiority Glimepiride Over Sitagliptin Naive Type 2 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Inclusion criterion : Subject na√Øve treatment HbA1c &gt; 8.5 11 % Lipid lowering therapy , antihypertensive , hormonal substitute , thyroid hormone substitute , contraceptive allow long kept stable dose Exclusion criterion : Treatment oral antidiabetic insulin Known type 1 Diabetes Mellitus Pregnant breast feeding woman Ketoacidosis history History sensitivity active substance Renal dysfunction : serum creatinine &gt; = 1.5 mg/dL male subject &gt; = 1.4 mg/dL female subject Liver impairment ( ALT , AST &gt; 3fold upper limit normal range ) Systemic corticosteroid treatment 3 month prior study study Drug alcohol abuse history Patients history acute coronary syndrome , cerebrovascular events/transient ischaemic attack last three month Presence condition ( medical , psychological , social geographic ) current previously see accord Investigators judgment jeopardize safety restrict participation patient study Neoplasias The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>